Retrospective analysis of the clinicopathological characteristics of gastrointestinal neuroendocrine neoplasms (Q35942994)

11 August 2017

Retrospective analysis of the clinicopathological characteristics of gastrointestinal neuroendocrine neoplasms (English)

1 reference

11 August 2017

Zhiqiang Wang

1

1 reference

11 August 2017

Wenliang Li

2

1 reference

11 August 2017

Tianxing Chen

3

1 reference

11 August 2017

Jun Yang

4

1 reference

11 August 2017

Lilin Luo

5

1 reference

11 August 2017

Lianyu Zhang

6

1 reference

11 August 2017

Baocun Sun

7

1 reference

11 August 2017

Rui Liang

8

1 reference

11 August 2017

13 July 2015

1 reference

Experimental and Therapeutic Medicine

11 August 2017

1 reference

11 August 2017

10

1 reference

11 August 2017

1084-1088

1 reference

11 August 2017

3

1 reference

Neuroendocrine tumors of the gastrointestinal tract: Case reports and literature review

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533220

Clinically detected gastroenteropancreatic neuroendocrine tumors are on the rise: epidemiological changes in Germany

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533220

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533220

Neuroendocrine neoplasms of the GI tract: the role of cytotoxic chemotherapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533220

Histopathology of gastrointestinal neuroendocrine neoplasms

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533220

Everolimus plus octreotide long-acting repeatable in patients with colorectal neuroendocrine tumors: a subgroup analysis of the phase III RADIANT-2 study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533220

Place of surgical resection in the treatment strategy of gastrointestinal neuroendocrine tumors.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533220

Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533220

The impact of incidental identification on the stage at presentation of lower gastrointestinal carcinoids

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533220

Management of early gastrointestinal neuroendocrine neoplasms

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533220

The epidemiology of gastroenteropancreatic neuroendocrine tumors.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533220

Surgical treatment of gastrointestinal neuroendocrine tumors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533220

Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE).

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533220

Treatment of advanced disease in patients with well-differentiated neuroendocrine tumors.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533220

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533220

Updated population-based review of carcinoid tumors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533220

Clinical and prognostic features of rectal neuroendocrine tumors.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533220

Surgical prognostic factors of gastroenteropancreatic neuroendocrine tumors (GEP NET)

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533220

Surgical management of neuroendocrine tumors of the gastrointestinal tract.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533220

Gastroenteropancreatic neuroendocrine tumors: incidence and treatment outcome in a single institution in Korea.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533220

Prognosis and survival in patients with gastrointestinal tract carcinoid tumors

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4533220

Plasma chromogranin A levels predict survival and tumor response in patients with advanced gastroenteropancreatic neuroendocrine tumors

14 November 2018

1 reference

12 December 2020

Prognostic Clinicopathologic Factors in Longitudinally Followed Patients With Metastatic Small Bowel Carcinoid Tumors

1 reference

12 December 2020

Alterations of E-cadherin, alpha-catenin and beta-catenin expression in neuroendocrine tumors of the gastrointestinal tract

1 reference

12 December 2020

[Incidence, pathology and clinical course and symptoms of neuroendocrine gastrointestinal tumours]

1 reference

12 December 2020

[Surgical treatment of gastroentero-pancreatic neuroendocrine tumor]

1 reference

12 December 2020

The classification of carcinoid tum ours

1 reference

12 December 2020

Proposed Staging System for Colon Carcinoid Tumors Based on an Analysis of 2,459 Patients

1 reference

12 December 2020

Chromogranin A is a reliable biomarker for gastroenteropancreatic neuroendocrine tumors in an Asian population of patients

1 reference

12 December 2020

Identifiers

DOI

10.3892/ETM.2015.2634

0 references

1 reference

11 August 2017

1 reference